⌘K

Login Start Free

Home/Filings/4/0001209191-21-020946

4//SEC Filing

MacPhee John A 4

Accession 0001209191-21-020946

CIK 0001328143other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 5:20 PM ET

Size

6.9 KB

Accession

0001209191-21-020946

Insider Transaction Report

Form 4

Period: 2021-03-12

Adamas Pharmaceuticals IncADMS

Director

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2021-03-12−192,000→ 0 total
Exercise: $0.67Exp: 2021-11-15→ Common Stock (192,000 underlying)
Exercise/Conversion
Common Stock
2021-03-12$0.67/sh+192,000$127,680→ 197,000 total

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeother

Related Parties

1

filerCIK 0001339976

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 5:20 PM ET
Size: 6.9 KB

View on SEC.gov